Filing Flows › BioCorRx (BICX) › Q1 2026 › vs Q1 2025
BioCorRx (BICX) Q1 2026 vs Q1 2025 (year over year)
BioCorRx's revenue rose $80K (+59%) from $135K in Q1 2025 to $215K in Q1 2026.
BioCorRx, Q1 2026: revenue $215K (+59% year over year), operating margin -445.6%, net loss $860K, operating cash flow −$433K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $215K | $135K | $80K | +59% |
| Other income, net | $96K | $86K | $10K | +12% |
| Net loss | $860K | $852K | $8K | +1% |
| Costs & expenses | $1.2M | $1.1M | $98K | +9% |
| Operating costs | $1.2M | $1.1M | $98K | +9% |
| Research & development | $352K | $162K | $190K | +118% |
| SG&A | $775K | $886K | −$111K | -12% |
| Other operating costs | $18K | $25K | −$7K | -29% |
| Operating cash sources | $860K | $852K | $8K | +1% |
| Depreciation & amortization | $11K | $25K | −$14K | -55% |
| Share-based compensation | $108K | $151K | −$43K | -28% |
| Working capital & other | $307K | −$14K | $321K | — |
| Cash used in operations | $433K | $690K | −$257K | -37% |
| Net loss absorbed | $860K | $852K | $8K | +1% |
Questions
How much did BioCorRx's revenue grow year over year in Q1 2026?
BioCorRx's revenue rose $80K (+59%) from $135K in Q1 2025 to $215K in Q1 2026.